Radiotheraphy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology

• 

  Año 2005, Vol. 76, Número 1

  • The ¿/ß ratio for prostate cancer: What is it, really?

    Mark A. Ritter, Søren M. Bentzen

    págs. 1-3

    

  • Bicalutamide (`Casodex¿) 150mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: Results from the randomised Early Prostate Cancer Programme

    William A. See, Jon Armstrong, Manfred P. Wirth, Chris J. Tyrrell, Clive Morris, Heather Payne, David G. McLeod, Peter Iversen

    págs. 4-10

    

  • A phase II study of localized prostate cancer treated to 75.6Gy with 3D conformal radiotherapy

    Tara Rosewall, Joan Sweet, Mary Gospodarowicz, Charles Catton, Alan Nichol, Ants Toi, Rob Bristow, Juanita Crook, Michael McLean, Peter Chung, Gina Lockwood, Andrew Bayley, Lorella Divanbiegi, Michael Milosevic, Padraig Warde

    págs. 11-17

    

  • The sensitivity of dose distributions for organ motion and set-up uncertainties in prostate IMRT

    Ben J. Mijnheer, Luc J. Bos, Marcel van Herk, Joris van der Geer, Joos V. Lebesque, Eugène M.F. Damen

    págs. 18-26

    

  • 3D conformal radiation therapy for prostate cancer in elderly patients

    Reinhard Thamm, Andreas Schumertl, Raymonde Busch, Michael Molls, Hans Geinitz, Frank B. Zimmermann

    págs. 27-34

    

  • The impact of organ motion on intestine doses and complication probabilities in radiotherapy of bladder cancer

    Yngve Kvinnsland, Ludvig Paul Muren

    págs. 43-47

    

  • Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma

    Morten Hoyer, Frey Eberholst, Svend Aage Engelholm, Lars Ohlhuis, Anders Traberg, Jorgen Pedersen, Lisa Sengelov, Hanne Nellemann, Hans von der Maase, Henrik Roed, Anne Kiil Berthelsen

    págs. 48-53

    

  • A phase I study of concurrent 9-nitro-20(s)-camptothecin (9NC/Orathecin) and radiation therapy in the treatment of locally advanced adenocarcinoma of the pancreas

    Adrian Scott Pearson, Karen L. Tedesco, Ken Wyman, Robert Daniel Beauchamp, Mace Rothenberg, Carol Caillouette, Hak Choy, A. Craig Lockhart, Yu Shyr, Jordan Berlin, Nipun Merchant, Bapsi Chakravarthy

    págs. 54-58

    

  • Epidemic and endemic Kaposi's sarcoma: A comparison of outcomes and survival after radiotherapy

    Awusi Kavuma, Joseph B. Kigula-Mugambe

    págs. 59-62

    

  • Initial patient imaging with an optimised radiotherapy beam for portal imaging

    Stella Flampouri, Helen A. McNair, Frank Verhaegen, Mike Partridge, Christopher M. Nutting, Ellen M. Donovan, Philip M. Evans

    págs. 63-71

    

  • Feasibility of cranio-spinal axis radiation with the Hi-Art tomotherapy system

    Nikos Papanikolaou, Vaneerat Ratanatharathorn, Emad Youssef, Yulong Yan, José A. Peñagarícano

    págs. 72-78

    

  • Monte Carlo calculation of the TG-43 dosimetric parameters of a new BEBIG Ir-192 HDR source

    Facundo Ballester, D. Granero-Cabañero, José Pérez Calatayud

    págs. 79-85

    

  • Clinical quality assurance for ¹⁰⁶Ru ophthalmic applicators

    Michael Bamberg, Thomas Haug, Fridtjof Nüsslin, Theodor W. Kaulich, Jens Zurheide

    págs. 86-92

    

  • Influence of radiotherapy on the latest generation of pacemakers

    Egon Scheepers, Coen W. Hurkmans, Bob G.F. Springorum, Hans Uiterwaal

    págs. 93-98

    

  • Magnetic resonance imaging anatomy of the prostate and periprostatic area: a guide for radiotherapists

    Gert O. De Meerleer, Wilfried J. De Neve, Geert M. Villeirs, Koenraad L.Verstraete

    págs. 99-106

    

  • Comment on: ¿HIV infection and invasive cervical cancers, treatment with radiation therapy: toxicity and outcome¿ [Radiother Oncol 2005;74:31¿35, Shrivastava et al.]

    Mustafa Cengiz, Ferah Yildiz, Gokhan Ozyigit, Ugur Selek, Ibtisam Lale Atahan

    págs. 107-108

    

  • Reply to the comments from Selek et al. [re: Radiother Oncol 2005;74:31¿35]

    S.K. Shrivastava, K.A. Dinshaw, R. Engineer

    pág. 108